Chevy Chase Trust
WST icon

Chevy Chase Trust’s West Pharmaceutical WST Stock Holding History

Chevy Chase Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.88M Sell
35,443
-1,032
-3% -$257K 0.03% 426
2025
Q4 		$10M Sell
36,475
-223
-0.6% -$61K 0.03% 412
2025
Q3 		$9.63M Sell
36,698
-1,250
-3% -$304K 0.03% 413
2025
Q2 		$8.3M Sell
37,948
-34
-0.1% -$7.27K 0.02% 436
2025
Q1 		$8.5M Sell
37,982
-318
-0.8% -$87.6K 0.03% 429
2024
Q4 		$12.5M Sell
38,300
-890
-2% -$280K 0.04% 358
2024
Q3 		$11.8M Sell
39,190
-627
-2% -$192K 0.04% 377
2024
Q2 		$13.1M Sell
39,817
-1,158
-3% -$409K 0.04% 335
2024
Q1 		$16.2M Sell
40,975
-356
-0.9% -$132K 0.05% 301
2023
Q4 		$14.6M Sell
41,331
-187
-0.5% -$66.2K 0.05% 309
2023
Q3 		$15.6M Sell
41,518
-1,194
-3% -$462K 0.06% 279
2023
Q2 		$16.3M Sell
42,712
-311
-0.7% -$111K 0.06% 284
2023
Q1 		$14.9M Buy
43,023
+443
+1% +$129K 0.06% 300
2022
Q4 		$10M Sell
42,580
-2,635
-6% -$624K 0.04% 369
2022
Q3 		$11.1M Buy
45,215
+480
+1% +$146K 0.05% 347
2022
Q2 		$13.5M Buy
44,735
+186
+0.4% +$60.5K 0.06% 307
2022
Q1 		$18.3M Buy
44,549
+122
+0.3% +$47.8K 0.06% 280
2021
Q4 		$20.8M Sell
44,427
-995
-2% -$428K 0.07% 264
2021
Q3 		$19.3M Sell
45,422
-1,620
-3% -$683K 0.07% 261
2021
Q2 		$16.9M Sell
47,042
-2,692
-5% -$889K 0.06% 299
2021
Q1 		$14M Sell
49,734
-3,482
-7% -$997K 0.05% 340
2020
Q4 		$15.1M Sell
53,216
-1,538
-3% -$432K 0.05% 312
2020
Q3 		$15.1M Sell
54,754
-4,473
-8% -$1.18M 0.06% 288
2020
Q2 		$13.5M Buy
+59,227
New +$11.6M 0.05% 312

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chevy Chase Trust's WST Position: Q1 2026 in Review

Chevy Chase Trust reduced its West Pharmaceutical (WST) stake by 2.8% in Q1 2026, selling an estimated $257K and leaving 35,443 shares worth $8.88M. The position accounts for 0.03% of the portfolio, ranked #426.

Chevy Chase Trust first reported a position in WST in Q2 2020 and has held it in 24 quarters since. The position peaked at $20.8M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Chevy Chase Trust held 35,443 shares of West Pharmaceutical worth $8.88M as of Q1 2026.
  • Chevy Chase Trust sold 1,032 West Pharmaceutical shares in Q1 2026, an estimated $257K.
  • West Pharmaceutical made up 0.03% of Chevy Chase Trust's portfolio in Q1 2026, its #426 holding.
  • Chevy Chase Trust first reported a position in West Pharmaceutical in Q2 2020 and has held it in 24 quarters since.
  • Chevy Chase Trust's West Pharmaceutical position peaked at $20.8M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.